Dianthus Therapeutics
Price & Volume
Stats
See moreOpen | $81.57 |
Previous Close | $81.57 |
Day Range | $78.60-$82.14 |
52W Range | $32.22-$117.88 |
Market Cap | $4.5B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $1.9M |
Revenue Growth (YoY) | 294.3% |
Gross Profit (12 Mos) | $1.9M |
Diluted EPS | -$4.23 |
News
See moreYahoo Finance • 19 days ago
Can Dianthus Therapeutics (DNTH) Stay Undervalued Following Its $500 Million Stock Offering?
Yahoo Finance • last month
UiPath downgraded, Shell upgraded: Wall Street's top analyst calls
Yahoo Finance • 2 months ago
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?
Yahoo Finance • 2 months ago
Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
About
CEO | Mr. Marino Garcia M.B.A. |
CFO | Mr. Ryan Savitz |
Address | 7 Times Square, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 92 |